Abstract
Introduction
Patients undergoing transsphenoidal pituitary surgery (TSS) are at risk for several serious complications, including the syndrome of inappropriate antidiuretic hormone and subsequent hyponatremia.
Objective
In this study, we examined the effect of 1 week of post-discharge fluid restriction to 1.0 L daily on rates of post-operative readmission for hyponatremia.
Methods
We retrospectively analyzed all patients undergoing TSS from 2008 to 2014 and prospectively recorded patient data from 2015 to 2017. Patients were divided into a control cohort (2008–2014), who were discharged with instructions to drink to thirst; and an intervention cohort (2015–2017) who were instructed to drink less than 1.0 L daily for 1 week post-operatively.
Results
This study included 788 patients; 585 (74.2%) in the control cohort and 203 (25.8%) in the intervention cohort. Overall, 436 (55.3%) were women, the median age was 47 (range 15–89), and average BMI was 29.4 kg/m2 (range 17.7–101.7). Patients were relatively well matched. Of patients in the intervention group, none was readmitted for hyponatremia (0/203), compared to 3.41% (20/585) in the control group (p = 0.003). Patients in the intervention group also had significantly higher post-operative week one sodium levels (140.1 vs 137.5 mEq/L; p = 0.002). No fluid balance complications occurred in patients who followed this protocol.
Conclusion
Hyponatremia can be a life-threatening complication of TSS, and prevention of readmission for hyponatremia can help improve patient safety and decrease costs. Mandatory post-discharge fluid restriction is a simple and inexpensive intervention associated with decreased rates of readmission for hyponatremia and normal post-operative sodium levels.
Similar content being viewed by others
References
Bohl MA, Ahmad S, White WL, Little AS (2017) Implementation of a postoperative outpatient care pathway for delayed hyponatremia following transsphenoidal surgery. Neurosurgery. doi:10.1093/neuros/nyx151
Corona G, Giuliani C, Parenti G et al (2016) The economic burden of hyponatremia: systematic review and meta-analysis. Am J Med 129(8):823–835.e4
Asemota AO, Ishii M, Brem H, Gallia GL (2017) Comparison of complications, trends, and costs in endoscopic vs microscopic pituitary surgery: analysis from a US Health Claims Database. Neurosurgery 81(3):458–472
Halvorsen H, Ramm-Pettersen J, Josefsen R et al (2014) Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures. Acta Neurochir 156(3):441–449
Ciric I, Ragin A, Baumgartner C, Pierce D (1997) Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40(2):225–236 (discussion 236–227)
Ausiello JC, Bruce JN, Freda PU (2008) Postoperative assessment of the patient after transsphenoidal pituitary surgery. Pituitary 11(4):391–401
Sata A, Hizuka N, Kawamata T, Hori T, Takano K (2006) Hyponatremia after transsphenoidal surgery for hypothalamo-pituitary tumors. Neuroendocrinology 83(2):117–122
Hussain NS, Piper M, Ludlam WG, Ludlam WH, Fuller CJ, Mayberg MR (2013) Delayed postoperative hyponatremia after transsphenoidal surgery: prevalence and associated factors. J Neurosurg 119(6):1453–1460
Jahangiri A, Wagner J, Han SW et al (2014) Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations. J Neurosurg 121(1):67–74
Barber SM, Liebelt BD, Baskin DS (2014) Incidence, etiology and outcomes of hyponatremia after transsphenoidal surgery: experience with 344 consecutive patients at a single tertiary center. J Clin Med 3(4):1199–1219
Kelly DF, Laws ER Jr, Fossett D (1995) Delayed hyponatremia after transsphenoidal surgery for pituitary adenoma: report of nine cases. J Neurosurg 83(2):363–367
Lee JI, Cho WH, Choi BK, Cha SH, Song GS, Choi CH (2008) Delayed hyponatremia following transsphenoidal surgery for pituitary adenoma. Neurol Med Chir 48(11):489–492 (discussion 492–484).
Cusick JF, Hagen TC, Findling JW (1984) Inappropriate secretion of antidiuretic hormone after transsphenoidal surgery for pituitary tumors. N Engl J Med 311(1):36–38
Cote DJ, Alzarea A, Acosta MA et al (2016) Predictors and rates of delayed symptomatic hyponatremia after transsphenoidal surgery: a systemastic review. World Neurosurg 88:1–6
Zada G, Liu CY, Fishback D, Singer PA, Weiss MH (2007) Recognition and management of delayed hyponatremia following transsphenoidal pituitary surgery. J Neurosurg 106(1):66–71
Hensen J, Henig A, Fahlbusch R, Meyer M, Boehnert M, Buchfelder M (1999) Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol 50(4):431–439
Belzer JS, Williams CN, Riva-Cambrin J, Presson AP, Bratton SL (2014) Timing, duration, and severity of hyponatremia following pediatric brain tumor surgery*. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and. Crit Care Soc 15(5):456–463
Blair ET, Clemmer JS, Harkey HL, Hester RL, Pruett WA (2017) Physiological mechanisms of water and electrolyte disturbances following transsphenoidal pituitary surgery. World Neurosurg. doi:10.1016/j.wneu.2017.07.175
Hannon MJ, Thompson CJ (2014) Neurosurgical hyponatremia. J Clin Med 3(4):1084–1104
Andrews BT, Fitzgerald PA, Tyrell JB, Wilson CB (1986) Cerebral salt wasting after pituitary exploration and biopsy: case report. Neurosurgery 18(4):469–471
Guerrero R, Pumar A, Soto A et al (2007) Early hyponatraemia after pituitary surgery: cerebral salt-wasting syndrome. Eur J Endocrinol 156(6):611–616
Cote DJ, Dasenbrock HH, Muskens IS et al (2017) Readmission and other adverse events after transsphenoidal surgery: prevalence, timing, and predictive factors. J Am Coll Surg 224(5):971–979
Jahangiri A, Wagner J, Tran MT et al (2013) Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations. J Neurosurg 119(6):1478–1483
Matsuyama J, Ikeda H, Sato S, Yamamoto K, Ohashi G, Watanabe K (2014) Early water intake restriction to prevent inappropriate antidiuretic hormone secretion following transsphenoidal surgery: low BMI predicts postoperative SIADH. Eur J Endocrinol 171(6):711–716
Takeuchi K, Nagatani T, Okumura E, Wakabayashi T (2014) A novel method for managing water and electrolyte balance after transsphenoidal surgery: preliminary study of moderate water intake restriction. Nagoya J Med Sci 76(1–2):73–82
Choong K, Arora S, Cheng J et al (2011) Hypotonic versus isotonic maintenance fluids after surgery for children: a randomized controlled trial. Pediatrics 128(5):857–866
Jane JA Jr, Kiehna E, Payne SC, Early SV, Laws ER (2010) Jr. Early outcomes of endoscopic transsphenoidal surgery for adult craniopharyngiomas. Neurosurg Focus 28(4):E9
Barkhoudarian G, Zada G, Laws ER (2014) Endoscopic endonasal surgery for nonadenomatous sellar/parasellar lesions. World Neurosurg 82(6 Suppl):S138–S146
Jagannathan J, Kanter AS, Sheehan JP, Jane JA Jr, Laws ER Jr (2007) Benign brain tumors: sellar/parasellar tumors. Neurol Clin 25(4):1231–1249
Cote DJ, Wiemann R, Smith TR, Dunn IF, Al-Mefty O, Laws ER (2015) The expanding spectrum of disease treated by the transnasal, transsphenoidal microscopic and endoscopic anterior skull base approach: a single-center experience 2008–2015. World Neurosurg 84(4):899–905
Cote DJ, Besasie BD, Hulou MM, Yan SC, Smith TR, Laws ER (2016) Transsphenoidal surgery for Rathke’s cleft cyst can reduce headache severity and frequency. Pituitary 19(1):57–64
Smith TR, Hulou MM, Huang KT et al (2015) Complications after transsphenoidal surgery for patients with Cushing’s disease and silent corticotroph adenomas. Neurosurg Focus 38(2):E12
Breshears JD, Jiang B, Rowland NC, Kunwar S, Blevins LS (2013) Use of conivaptan for management of hyponatremia following surgery for Cushing’s disease. Clin Neurol Neurosurg 115(11):2358–2361
Adams JR, Blevins LS Jr, Allen GS, Verity DK, Devin JK (2006) Disorders of water metabolism following transsphenoidal pituitary surgery: a single institution’s experience. Pituitary 9(2):93–99
Pratheesh R, Swallow DM, Rajaratnam S et al (2013) Incidence, predictors and early post-operative course of diabetes insipidus in paediatric craniopharygioma: a comparison with adults. Child’s Nerv Syst 29(6):941–949
Mukherjee KK, Dutta P, Singh A et al (2014) Choice of fluid therapy in patients of craniopharyngioma in the perioperative period: a hospital-based preliminary study. Surg Neurol Int 5:105
Hendricks BL, Shikary TA, Zimmer LA (2016) Causes for 30-day readmission following transsphenoidal surgery. Otolaryngol–Head Neck Surg 154(2):359–365
Funding
National Institutes of Health Training Grant T32 CA 009001 (DJC).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
We have nothing to disclose.
Rights and permissions
About this article
Cite this article
Burke, W.T., Cote, D.J., Iuliano, S.I. et al. A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgery. Pituitary 21, 25–31 (2018). https://doi.org/10.1007/s11102-017-0843-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-017-0843-5